Clinical Study of Balchaturbhadra Churna in the Management of Kasa Roga (Allergic Bronchitis) in Children

Kasa, a condition resembling allergic bronchitis in children, is characterized by irritation of the respiratory mucosa leading to coughing. This study aimed to evaluate the clinical efficacy of Balchaturbhadra Churna in managing Kasa in children aged 3 to 10 years. A total of 10 children with mild persistent allergic bronchitis were enrolled in a single-arm, open-label trial. The drug was administered for 30 days, with dosage determined using Young's formula. The primary endpoints were alleviation of subjective symptoms (e.g., chest pain, dry cough, hoarseness) and improvement in objective parameters (e.g., CBC, ESR, WBC). Significant improvements were observed in both subjective symptoms, such as reduced chest pain (55% relief), and objective parameters, including a reduction in ESR (45.35% relief) and eosinophils (34.5% relief). The therapy demonstrated statistically significant results in reducing symptoms of Kasa, with no adverse effects reported during the study. Thus, Balchaturbhadra Churna was proved to be a safe and effective treatment for managing Kasa in children. Key words: Allergic, Ayurveda, Ativisha, Balchaturbhadra, Children, Cough, Kasa, Musta, Pippali, Karkashingi.